Trautec Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
425
- Latest Deal Type
-
IPO
- Investors
-
10
Trautec General Information
Description
Developer of recombinant collagen-based biomaterials designed for life and health new materials field. The company aims to develop recombinant human-derived collagen products, which can be applied in the fields of medicine, medical regeneration, and medical aesthetics, providing customers with innovative and high-quality products.
Contact Information
Website
www.trautec.com.cnCorporate Office
- No. 28 Shuanglong Road, Jintan Development Zone
- Changzhou, Jiangsu 213212
- China
Corporate Office
- No. 28 Shuanglong Road, Jintan Development Zone
- Changzhou, Jiangsu 213212
- China
Trautec Timeline
Trautec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 11-Nov-2024 | Completed | Profitable | |||
| 6. Secondary Transaction - Private | 18-Jun-2024 | Completed | Profitable | |||
| 5. Later Stage VC (Series B) | 18-Sep-2023 | Completed | Profitable | |||
| 4. Later Stage VC (Series A) | 16-Aug-2022 | Completed | Profitable | |||
| 3. Secondary Transaction - Private | 16-Aug-2022 | Completed | Profitable | |||
| 2. Later Stage VC | 30-Sep-2021 | $4.94M | $4.94M | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2021 | $76.4K | Completed | Generating Revenue |
Trautec Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,276,600 | $3.44 | $3.44 | 1x | $3.44 | 3.07% |
Trautec Comparisons
Industry
Financing
Details
Trautec Competitors (2)
One of Trautec’s 2 competitors is Fujifilm Diosynth Biotechnologies, a Corporate Backed or Acquired company based in College Station, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fujifilm Diosynth Biotechnologies | Corporate Backed or Acquired | College Station, TX | ||||
| Eluminex Biosciences | Venture Capital-Backed | Suzhou, China |
Trautec Patents
Trautec Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026145649-A1 | Recombinant type iv collagen, and preparation method therefor and use thereof | Pending | 31-Dec-2024 | ||
| WO-2026119282-A1 | Recombinant type vii collagen having skin-whitening effect, preparation method therefor and use thereof | Pending | 05-Dec-2024 | ||
| WO-2026108889-A1 | Recombinant type i collagen and use thereof | Pending | 22-Nov-2024 | ||
| WO-2025247065-A1 | Preparation method for yeast-expressed type i recombinant human collagen with tri-helical structure and use thereof | Pending | 30-May-2024 | ||
| WO-2025247066-A1 | Preparation method for yeast-expressed type iii recombinant human collagen with tri-helical structure and use thereof | Pending | 30-May-2024 | C12N15/815 |
Trautec Signals
Trautec Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CLSA Capital Partners | Asset Manager | Minority | ||
| L Catterton | PE/Buyout | Minority | ||
| Mingfeng Capital | PE/Buyout | Minority | ||
| Shenzhen CDF Capital | Venture Capital | Minority | ||
| Boyu Capital | Asset Manager | Minority |
Trautec FAQs
-
When was Trautec founded?
Trautec was founded in 2015.
-
Where is Trautec headquartered?
Trautec is headquartered in Changzhou, China.
-
What is the size of Trautec?
Trautec has 425 total employees.
-
What industry is Trautec in?
Trautec’s primary industry is Specialty Chemicals.
-
Is Trautec a private or public company?
Trautec is a Private company.
-
What is Trautec’s current revenue?
The current revenue for Trautec is .
-
How much funding has Trautec raised over time?
Trautec has raised $55M.
-
Who are Trautec’s investors?
CLSA Capital Partners, L Catterton, Mingfeng Capital, Shenzhen CDF Capital, and Boyu Capital are 5 of 10 investors who have invested in Trautec.
-
Who are Trautec’s competitors?
Fujifilm Diosynth Biotechnologies and Eluminex Biosciences are competitors of Trautec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process